Description
Targeted Therapy for Leukemia
DASANIX (Dasatinib) 100mg Tablets 30’s provide an effective oral treatment for adults diagnosed with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib is a tyrosine kinase inhibitor (TKI) that works by blocking proteins responsible for the growth of cancer cells.
How DASANIX Works
Dasatinib inhibits BCR-ABL and other kinases involved in the abnormal signalling pathways that drive leukemia cell proliferation. By interrupting these signals, DASANIX (Dasatinib) 100mg Tablets 30’s help slow disease progression, reduce cancer cell counts, and support long-term remission.
Dosage and Administration
Patients usually take one 100mg tablet once daily, with or without food. It’s important to swallow the tablet whole and take it at the same time each day. Dosage may vary depending on the stage of disease, patient tolerance, and response to treatment. Always follow your oncologist’s instructions closely.
Monitoring and Side Effects
Routine monitoring of blood counts, liver function, and cardiac health is essential during treatment. Common side effects include fluid retention, fatigue, nausea, diarrhoea, and headache. More serious risks, such as low blood cell counts or pleural effusion, require immediate medical attention. Fortunately, with regular monitoring and prompt care, most side effects can be managed effectively.
High-Quality, Reliable Formulation
Manufactured under strict pharmaceutical standards, DASANIX ensures consistent potency and purity. It is available only by prescription and should be taken under specialist supervision.
Supporting Long-Term Leukemia Management
With proven clinical effectiveness, DASANIX plays a crucial role in controlling CML and Ph+ ALL. When taken as prescribed, it can significantly improve prognosis and help patients lead fuller, healthier lives.
Reviews
There are no reviews yet.